Please assess the completion status of the following clinical trial:

Trial Title: Application of S26E for Diabetic Foot Ulcer Healing

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Type 1 or type 2 Diabetes Mellitus~* Body Mass Index \<40 kg/m2~* Glycated Hemoglobin (HbA1c) \<10%~* Presence of a diabetic foot ulcer with the following features i) Owing to chronic peripheral sensorimotor diabetic neuropathy, with or without peripheral arterial disease (critical ischemia excluded as indexed by an Ankle-Brachial index \<0.4 ) ii) Persistence for \>12 weeks iii) Already following an adequate off-loading method~Exclusion Criteria:~* Presence of clinical signs of infection~* Inability or refusal to follow off-loading methods~* Ulcer surface area decline by \>15% during the run-in period~* Malignant disease (non-melanoma skin malignancy and healed thyroid malignancies excluded)~* Acute Charcot arthropathy~* Serious chronic Hepatic (Child-Pugh B or C), Renal (stage 4-5 CKD) or Heart (NYHA 3-4) disease~* Known hypersensitivity to the product or its contents~* Any random glucose measurement \>350 mg/dl during the run-in period

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Standard-of-care managed group (Type: ACTIVE_COMPARATOR): This group will receive the optimal standard-of-care for neuropathic/neuroischemic diabetic foot ulcers
- S26E (Type: EXPERIMENTAL): This group will receive the optimal standard-of-care for neuropathic/neuroischemic diabetic foot ulcers plus daily S26E application

Based on this trial design, predict the completion outcome and termination type (if applicable).